Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00256750
Show Display Options
Rank Status Study
1 Completed
Has Results
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Conditions: Kidney Transplantation;   Chronic Kidney Failure
Interventions: Drug: Cyclosporine (CsA);   Drug: Belatacept LI (less intensive);   Drug: Belatacept MI (more intensive)

Study has passed its completion date and status has not been verified in more than two years.